CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.

The global CAR T-Cell Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for CAR T-Cell Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for CAR T-Cell Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for CAR T-Cell Immunotherapy in Hematologic Malignancies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of CAR T-Cell Immunotherapy include AbbVie, Celgene, Kite Pharma, Oxford BioMedica, Novartis, Gilead, Pfizer, Cellectis and Bellicum, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for CAR T-Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR T-Cell Immunotherapy.

Report Scope

The CAR T-Cell Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CAR T-Cell Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CAR T-Cell Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CAR T-Cell Immunotherapy Market Report

Report Metric	Details
Report Name	CAR T-Cell Immunotherapy Market
Segment by Type	Monotherapy Combination Therapy
Segment by Application	Hematologic Malignancies Solid Malignancies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Celgene, Kite Pharma, Oxford BioMedica, Novartis, Gilead, Pfizer, Cellectis, Bellicum, Mustang Bio, CARsgen Therapeutics, Xyphos, Minerva Biotechnologies, Adaptimmune, Ziopharm Oncology, Aurora Biopharma, Creative Biolabs
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR T-Cell Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CAR T-Cell Immunotherapy Market report?

Ans: The main players in the CAR T-Cell Immunotherapy Market are AbbVie, Celgene, Kite Pharma, Oxford BioMedica, Novartis, Gilead, Pfizer, Cellectis, Bellicum, Mustang Bio, CARsgen Therapeutics, Xyphos, Minerva Biotechnologies, Adaptimmune, Ziopharm Oncology, Aurora Biopharma, Creative Biolabs

What are the Application segmentation covered in the CAR T-Cell Immunotherapy Market report?

Ans: The Applications covered in the CAR T-Cell Immunotherapy Market report are Hematologic Malignancies, Solid Malignancies

What are the Type segmentation covered in the CAR T-Cell Immunotherapy Market report?

Ans: The Types covered in the CAR T-Cell Immunotherapy Market report are Monotherapy, Combination Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Monotherapy

1.2.3 Combination Therapy

1.3 Market by Application

1.3.1 Global CAR T-Cell Immunotherapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hematologic Malignancies

1.3.3 Solid Malignancies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global CAR T-Cell Immunotherapy Market Perspective (2019-2030)

2.2 CAR T-Cell Immunotherapy Growth Trends by Region

2.2.1 Global CAR T-Cell Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 CAR T-Cell Immunotherapy Historic Market Size by Region (2019-2024)

2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Region (2025-2030)

2.3 CAR T-Cell Immunotherapy Market Dynamics

2.3.1 CAR T-Cell Immunotherapy Industry Trends

2.3.2 CAR T-Cell Immunotherapy Market Drivers

2.3.3 CAR T-Cell Immunotherapy Market Challenges

2.3.4 CAR T-Cell Immunotherapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CAR T-Cell Immunotherapy Players by Revenue

3.1.1 Global Top CAR T-Cell Immunotherapy Players by Revenue (2019-2024)

3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2019-2024)

3.2 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue

3.4 Global CAR T-Cell Immunotherapy Market Concentration Ratio

3.4.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2023

3.5 CAR T-Cell Immunotherapy Key Players Head office and Area Served

3.6 Key Players CAR T-Cell Immunotherapy Product Solution and Service

3.7 Date of Enter into CAR T-Cell Immunotherapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 CAR T-Cell Immunotherapy Breakdown Data by Type

4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2019-2024)

4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2025-2030)

5 CAR T-Cell Immunotherapy Breakdown Data by Application

5.1 Global CAR T-Cell Immunotherapy Historic Market Size by Application (2019-2024)

5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America CAR T-Cell Immunotherapy Market Size (2019-2030)

6.2 North America CAR T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America CAR T-Cell Immunotherapy Market Size by Country (2019-2024)

6.4 North America CAR T-Cell Immunotherapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CAR T-Cell Immunotherapy Market Size (2019-2030)

7.2 Europe CAR T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe CAR T-Cell Immunotherapy Market Size by Country (2019-2024)

7.4 Europe CAR T-Cell Immunotherapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size (2019-2030)

8.2 Asia-Pacific CAR T-Cell Immunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2019-2024)

8.4 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CAR T-Cell Immunotherapy Market Size (2019-2030)

9.2 Latin America CAR T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America CAR T-Cell Immunotherapy Market Size by Country (2019-2024)

9.4 Latin America CAR T-Cell Immunotherapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size (2019-2030)

10.2 Middle East & Africa CAR T-Cell Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2019-2024)

10.4 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Detail

11.1.2 AbbVie Business Overview

11.1.3 AbbVie CAR T-Cell Immunotherapy Introduction

11.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.1.5 AbbVie Recent Development

11.2 Celgene

11.2.1 Celgene Company Detail

11.2.2 Celgene Business Overview

11.2.3 Celgene CAR T-Cell Immunotherapy Introduction

11.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.2.5 Celgene Recent Development

11.3 Kite Pharma

11.3.1 Kite Pharma Company Detail

11.3.2 Kite Pharma Business Overview

11.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction

11.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.3.5 Kite Pharma Recent Development

11.4 Oxford BioMedica

11.4.1 Oxford BioMedica Company Detail

11.4.2 Oxford BioMedica Business Overview

11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction

11.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.4.5 Oxford BioMedica Recent Development

11.5 Novartis

11.5.1 Novartis Company Detail

11.5.2 Novartis Business Overview

11.5.3 Novartis CAR T-Cell Immunotherapy Introduction

11.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.5.5 Novartis Recent Development

11.6 Gilead

11.6.1 Gilead Company Detail

11.6.2 Gilead Business Overview

11.6.3 Gilead CAR T-Cell Immunotherapy Introduction

11.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.6.5 Gilead Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Detail

11.7.2 Pfizer Business Overview

11.7.3 Pfizer CAR T-Cell Immunotherapy Introduction

11.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.7.5 Pfizer Recent Development

11.8 Cellectis

11.8.1 Cellectis Company Detail

11.8.2 Cellectis Business Overview

11.8.3 Cellectis CAR T-Cell Immunotherapy Introduction

11.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.8.5 Cellectis Recent Development

11.9 Bellicum

11.9.1 Bellicum Company Detail

11.9.2 Bellicum Business Overview

11.9.3 Bellicum CAR T-Cell Immunotherapy Introduction

11.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.9.5 Bellicum Recent Development

11.10 Mustang Bio

11.10.1 Mustang Bio Company Detail

11.10.2 Mustang Bio Business Overview

11.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction

11.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.10.5 Mustang Bio Recent Development

11.11 CARsgen Therapeutics

11.11.1 CARsgen Therapeutics Company Detail

11.11.2 CARsgen Therapeutics Business Overview

11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction

11.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.11.5 CARsgen Therapeutics Recent Development

11.12 Xyphos

11.12.1 Xyphos Company Detail

11.12.2 Xyphos Business Overview

11.12.3 Xyphos CAR T-Cell Immunotherapy Introduction

11.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.12.5 Xyphos Recent Development

11.13 Minerva Biotechnologies

11.13.1 Minerva Biotechnologies Company Detail

11.13.2 Minerva Biotechnologies Business Overview

11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction

11.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.13.5 Minerva Biotechnologies Recent Development

11.14 Adaptimmune

11.14.1 Adaptimmune Company Detail

11.14.2 Adaptimmune Business Overview

11.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction

11.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.14.5 Adaptimmune Recent Development

11.15 Ziopharm Oncology

11.15.1 Ziopharm Oncology Company Detail

11.15.2 Ziopharm Oncology Business Overview

11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction

11.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.15.5 Ziopharm Oncology Recent Development

11.16 Aurora Biopharma

11.16.1 Aurora Biopharma Company Detail

11.16.2 Aurora Biopharma Business Overview

11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction

11.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.16.5 Aurora Biopharma Recent Development

11.17 Creative Biolabs

11.17.1 Creative Biolabs Company Detail

11.17.2 Creative Biolabs Business Overview

11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction

11.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2019-2024)

11.17.5 Creative Biolabs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Minerva Biotechnologies

List of Tables

Table 1. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Monotherapy

Table 3. Key Players of Combination Therapy

Table 4. Global CAR T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global CAR T-Cell Immunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global CAR T-Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global CAR T-Cell Immunotherapy Market Share by Region (2019-2024)

Table 8. Global CAR T-Cell Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global CAR T-Cell Immunotherapy Market Share by Region (2025-2030)

Table 10. CAR T-Cell Immunotherapy Market Trends

Table 11. CAR T-Cell Immunotherapy Market Drivers

Table 12. CAR T-Cell Immunotherapy Market Challenges

Table 13. CAR T-Cell Immunotherapy Market Restraints

Table 14. Global CAR T-Cell Immunotherapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global CAR T-Cell Immunotherapy Market Share by Players (2019-2024)

Table 16. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2023)

Table 17. Ranking of Global Top CAR T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by CAR T-Cell Immunotherapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players CAR T-Cell Immunotherapy Product Solution and Service

Table 21. Date of Enter into CAR T-Cell Immunotherapy Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global CAR T-Cell Immunotherapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2019-2024)

Table 25. Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2025-2030)

Table 27. Global CAR T-Cell Immunotherapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2019-2024)

Table 29. Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2025-2030)

Table 31. North America CAR T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America CAR T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America CAR T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe CAR T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe CAR T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe CAR T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific CAR T-Cell Immunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America CAR T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America CAR T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America CAR T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa CAR T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. AbbVie Company Detail

Table 47. AbbVie Business Overview

Table 48. AbbVie CAR T-Cell Immunotherapy Product

Table 49. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 50. AbbVie Recent Development

Table 51. Celgene Company Detail

Table 52. Celgene Business Overview

Table 53. Celgene CAR T-Cell Immunotherapy Product

Table 54. Celgene Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 55. Celgene Recent Development

Table 56. Kite Pharma Company Detail

Table 57. Kite Pharma Business Overview

Table 58. Kite Pharma CAR T-Cell Immunotherapy Product

Table 59. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 60. Kite Pharma Recent Development

Table 61. Oxford BioMedica Company Detail

Table 62. Oxford BioMedica Business Overview

Table 63. Oxford BioMedica CAR T-Cell Immunotherapy Product

Table 64. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 65. Oxford BioMedica Recent Development

Table 66. Novartis Company Detail

Table 67. Novartis Business Overview

Table 68. Novartis CAR T-Cell Immunotherapy Product

Table 69. Novartis Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 70. Novartis Recent Development

Table 71. Gilead Company Detail

Table 72. Gilead Business Overview

Table 73. Gilead CAR T-Cell Immunotherapy Product

Table 74. Gilead Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 75. Gilead Recent Development

Table 76. Pfizer Company Detail

Table 77. Pfizer Business Overview

Table 78. Pfizer CAR T-Cell Immunotherapy Product

Table 79. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 80. Pfizer Recent Development

Table 81. Cellectis Company Detail

Table 82. Cellectis Business Overview

Table 83. Cellectis CAR T-Cell Immunotherapy Product

Table 84. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 85. Cellectis Recent Development

Table 86. Bellicum Company Detail

Table 87. Bellicum Business Overview

Table 88. Bellicum CAR T-Cell Immunotherapy Product

Table 89. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 90. Bellicum Recent Development

Table 91. Mustang Bio Company Detail

Table 92. Mustang Bio Business Overview

Table 93. Mustang Bio CAR T-Cell Immunotherapy Product

Table 94. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 95. Mustang Bio Recent Development

Table 96. CARsgen Therapeutics Company Detail

Table 97. CARsgen Therapeutics Business Overview

Table 98. CARsgen Therapeutics CAR T-Cell Immunotherapy Product

Table 99. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 100. CARsgen Therapeutics Recent Development

Table 101. Xyphos Company Detail

Table 102. Xyphos Business Overview

Table 103. Xyphos CAR T-Cell Immunotherapy Product

Table 104. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 105. Xyphos Recent Development

Table 106. Minerva Biotechnologies Company Detail

Table 107. Minerva Biotechnologies Business Overview

Table 108. Minerva Biotechnologies CAR T-Cell Immunotherapy Product

Table 109. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 110. Minerva Biotechnologies Recent Development

Table 111. Adaptimmune Company Detail

Table 112. Adaptimmune Business Overview

Table 113. Adaptimmune CAR T-Cell Immunotherapy Product

Table 114. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 115. Adaptimmune Recent Development

Table 116. Ziopharm Oncology Company Detail

Table 117. Ziopharm Oncology Business Overview

Table 118. Ziopharm Oncology CAR T-Cell Immunotherapy Product

Table 119. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 120. Ziopharm Oncology Recent Development

Table 121. Aurora Biopharma Company Detail

Table 122. Aurora Biopharma Business Overview

Table 123. Aurora Biopharma CAR T-Cell Immunotherapy Product

Table 124. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 125. Aurora Biopharma Recent Development

Table 126. Creative Biolabs Company Detail

Table 127. Creative Biolabs Business Overview

Table 128. Creative Biolabs CAR T-Cell Immunotherapy Product

Table 129. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2019-2024) & (US$ Million)

Table 130. Creative Biolabs Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Global CAR T-Cell Immunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global CAR T-Cell Immunotherapy Market Share by Type: 2023 VS 2030

Figure 3. Monotherapy Features

Figure 4. Combination Therapy Features

Figure 5. Global CAR T-Cell Immunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global CAR T-Cell Immunotherapy Market Share by Application: 2023 VS 2030

Figure 7. Hematologic Malignancies Case Studies

Figure 8. Solid Malignancies Case Studies

Figure 9. CAR T-Cell Immunotherapy Report Years Considered

Figure 10. Global CAR T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global CAR T-Cell Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global CAR T-Cell Immunotherapy Market Share by Region: 2023 VS 2030

Figure 13. Global CAR T-Cell Immunotherapy Market Share by Players in 2023

Figure 14. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Immunotherapy as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2023

Figure 16. North America CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America CAR T-Cell Immunotherapy Market Share by Country (2019-2030)

Figure 18. United States CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe CAR T-Cell Immunotherapy Market Share by Country (2019-2030)

Figure 22. Germany CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific CAR T-Cell Immunotherapy Market Share by Region (2019-2030)

Figure 30. China CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America CAR T-Cell Immunotherapy Market Share by Country (2019-2030)

Figure 38. Mexico CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa CAR T-Cell Immunotherapy Market Share by Country (2019-2030)

Figure 42. Turkey CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia CAR T-Cell Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 45. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 46. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 47. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 48. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 49. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 50. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 51. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 52. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 53. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 54. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 55. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 56. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 57. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 58. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 59. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 60. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Color Detection Sensors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G9623

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Appendix Cancer Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2H1312

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions